Viral Genetics Inc.
2290 Huntington Drive
Suite 100
San Marino,
CA 91108
United States - Map
Phone: 626-334-5310
Fax: 626-334-5324
Web Site: http://www.viralgenetics.com
| Index Membership: | N/A | | Sector: | N/A | | Industry: | N/A | | Full Time Employees: | 2 |
|
| Viral Genetics, Inc., a development stage company, engages in the research and development of protein-based therapeutic and diagnostic products with applications in infectious disease, autoimmune conditions, and immunological deficiency. It develops its products based on thymus nuclear protein (TNP). The companys lead product includes VGV-X, for the treatment of HIV infection and AIDS. It also engages in the development of metabolic pathway disruption products; and techniques to optimize peptide-based drug therapies and related mechanisms of action for Lyme disease, multiple Sclerosis, and other diseases. The company was founded in 1995 and is based in San Marino, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Haig Keledjian , 47
Co-Founder, Chairman, Chief Exec. Officer, Pres, Chief Financial Officer, Principal Accounting Officer and Sec. |
N/A
| N/A | Ms. Monica Ord , 46
Sr. VP of Corp. Devel. & Communications |
N/A
| N/A | Dr. Richard J. Trauger Ph.D,
Chief Exec. Officer of MetaCytoLytics Inc |
N/A
| N/A | Ms. Wieslawa Giermakowska ,
Director of Research |
N/A
| N/A | Dr. C. Everett Koop M.D., 92
Special Advisor and Member of Advisory Board |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-06
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
Profile
